DrugPatentWatch Database Preview

Efinaconazole - Generic Drug Details

see a sample report or, see our see our flat-rate plans

What are the generic sources for efinaconazole and what is the scope of efinaconazole patent protection?
Efinaconazole is the generic ingredient in one branded drug marketed by Dow Pharm and is included in one NDA. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Efinaconazole has forty-four patent family members in twenty-one countries.

There are fourteen drug master file entries for efinaconazole. One supplier is listed for this compound.

Summary for efinaconazole

International Patents:	44
US Patents:	8
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	14
Suppliers / Packagers:	1
Bulk Api Vendors:	31
Clinical Trials:	2
Patent Applications:	27
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for efinaconazole
DailyMed Link:	efinaconazole at DailyMed

Pharmacology for efinaconazole

Ingredient-type	Azoles
Drug Class	Azole Antifungal

Synonyms for efinaconazole

(2R, 3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidyl)-1-(1,2,4-triazolyl)butan-2-ol
(2R,3R)-2-(2,4-Difluorofenil)-3-(4-metilenopiperidin-1-il)-1-(1H-1,2,4-triazin-1-il)butan-2-ol
(2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidyl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidino)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1- ylmethyl)-, (alphaR,betaR)-
164650-44-6
164905-19-5
2856AH
AC1LAJ21
AK315814
AKOS027323571
C18H22F2N4O
CHEBI:82718
CHEMBL2103877
Clenafin (TN)
CS-3500
CTK5J2975
D0G4BI
D10021
DB09040
DTXSID40167787
efinaconazol
Efinaconazole (JAN/USAN/INN)
Efinaconazole [USAN:INN]
Efinaconazole(KP-103)
efinaconazolum
HSDB 8341
HY-15660
IDP-108
J82SB7FXWB
JUBLIA
Jublia (TN)
KB-145948
KP-103
KP103
KS-00000SEK
MFCD00936407
MolPort-039-139-376
NFEZZTICAUWDHU-RDTXWAMCSA-N
SCHEMBL300738
UNII-J82SB7FXWB
ZINC6251

US Patents and Regulatory Information for efinaconazole

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Dow Pharm	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Dow Pharm	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Dow Pharm	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration